Principal Securities’s Insmed INSM Stock Holding History

Principal Securities’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$717K	Buy	6,728 +1,463	+28%	+$177K	0.01%	911
2026 Q1	$861K	Buy	5,265 +144	+3%	+$22.1K	0.01%	770
2025 Q4	$891K	Sell	5,121 -1,883	-27%	-$344K	0.01%	728
2025 Q3	$1.01M	Buy	7,004 +1,283	+22%	+$157K	0.02%	662
2025 Q2	$576K	Buy	5,721 +2,582	+82%	+$197K	0.01%	802
2025 Q1	$217K	Hold	3,139	–	–	﹤0.01%	1092
2024 Q4	$217K	Buy	3,139 +1,120	+55%	+$80.7K	﹤0.01%	1092
2024 Q3	$147K	Sell	2,019 -40	-2%	-$2.95K	﹤0.01%	1227
2024 Q2	$138K	Buy	2,059 +1,767	+605%	+$68.5K	﹤0.01%	1195
2024 Q1	$7.92K	Sell	292 -107	-27%	-$3K	﹤0.01%	2442
2023 Q4	$12.4K	Buy	+399	New	+$10.3K	﹤0.01%	2145

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Principal Securities's INSM Position: Q2 2026 in Review

Principal Securities increased its Insmed (INSM) stake by 28% in Q2 2026, buying an estimated $177K and bringing the position to 6,728 shares worth $717K. The position accounts for 0.01% of the portfolio, ranked #911.

Principal Securities first reported a position in INSM in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.01M in Q3 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Principal Securities held 6,728 shares of Insmed worth $717K as of Q2 2026.
Principal Securities bought 1,463 Insmed shares in Q2 2026, an estimated $177K.
Insmed made up 0.01% of Principal Securities's portfolio in Q2 2026, its #911 holding.
Principal Securities first reported a position in Insmed in Q4 2023 and has held it in 11 quarters since.
Principal Securities's Insmed position peaked at $1.01M in Q3 2025.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.